Cristina Felicani

Cristina Felicani


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2007 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
ECElisabetta Cervio
Elisabetta Cervio
UVUmberto Volta
Umberto Volta
MVManuela Verri
Manuela Verri
FBFederica Boschi
Federica Boschi
OPOrnella Pastoris
Ornella Pastoris
Roberto De GiorgioRoberto De Giorgio
Roberto De Giorgio

1 August 2011 in Pancreas
Verified
Journal Article
Closed access
Raffaele PezzilliRaffaele Pezzilli
Raffaele Pezzilli
MFMassimo Falconi
Massimo Falconi
AZAlessandro Zerbi
Alessandro Zerbi
RCRiccardo Casadei
Riccardo Casadei
LVLuana Valli
Luana Valli
AMAntonio Maria Morselli‐Labate
Antonio Maria Morselli‐Labate
The objective of the study was to evaluate clinical features and quality of life (QoL) in a 2-year follow-up study in subjects who underwent pancreatic head resection (PHR). One hundred ninety-seven patients with benign and malignant diseases who underwent PHR were studied. A dedicated clinical form and the European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire C-30 were administered at evaluation times (immediately before surgery and 6, 12, 18, and 24 months after discharge). A sample of 197 sex- and age-matched norms was also included into the study as reference group. Of the 197 patients studied, 164 (83.2%) had malignant disease, and 33 had benign disease (16.8%). At initial evaluation, global health was significantly lower (P = 0.001) in the study population as compared with the norms. At the end of the study, the QoL was not significantly different from the norms, although the QoL of the 30 patients with benign disease was significantly better than that of the 72 patients with malignant disease. The QoL before PHR was impaired in study patients before resection as compared with the normative population, whereas in patients who survived resection, it significantly improved in the 24 months after surgery.

1 January 2010 in Transplantation Proceedings
Verified
Journal Article
Closed access
Roberto De GiorgioRoberto De Giorgio
Roberto De Giorgio
Luigi RicciardielloLuigi Ricciardiello
Luigi Ricciardiello
Valeria NaponelliValeria Naponelli
Valeria Naponelli
MSM. Selgrad
M. Selgrad
GPG. Piazzi
G. Piazzi
VSV. Stanghellini
V. Stanghellini

1 July 2013 in Pancreas
Verified
Journal Article
Closed access
CSCarla Serra
Carla Serra
CFCristina Felicani
Cristina Felicani
EMElena Mazzotta
Elena Mazzotta
LPLydia Piscitelli
Lydia Piscitelli
MCMaria Luigia Cipollini
Maria Luigia Cipollini
Roberto De GiorgioRoberto De Giorgio
Roberto De Giorgio
Contrast-enhanced ultrasound (CEUS) has been developed to better characterize the microvasculature of solid masses in several organs, including the pancreas. In this study, we assessed CEUS accuracy in differentiating exocrine from endocrine pancreatic tumors. A total of 127 patients with single, undetermined pancreatic masses were prospectively examined with transabdominal ultrasound and CEUS, before surgical resection or percutaneous biopsy. Exocrine and endocrine pancreatic tumors showed different intralesional vascularization patterns: 98.9% (90/91) of exocrine tumors were hypoenhancing, whereas 95.8 % (23/24) of endocrine tumors had a hypervascular supply. A hypoenhancing pattern, indicative of ductal adenocarcinoma, had a significant (P < 0.001) diagnostic accuracy of 91.3% with a sensitivity of 96.8%, a specificity of 85.3%, a positive predictive value and a negative predictive value of 94.7% and 90.6%, respectively. The hyperenhancing pattern, indicative of endocrine tumors, had a significant (P = 0.031) diagnostic accuracy of 73.8% with a sensitivity of 83.3%, a specificity of 60.0%, a positive predictive value and negative predictive value of 83.3% and 60.0%, respectively. Contrast-enhanced ultrasound has a valuable diagnostic accuracy in differentiating exocrine from endocrine pancreatic tumors, which is a fundamental step to address appropriate histological evaluation, therapeutic approach, and follow-up.

1 July 2016 in Liver International
Verified
Journal Article
Closed access
PDF file
FCFabio Conti
Fabio Conti
CSCarla Serra
Carla Serra
RVRanka Vukotic
Ranka Vukotic
EFErica Fiorini
Erica Fiorini
CFCristina Felicani
Cristina Felicani
PAPietro Andreone
Pietro Andreone

1 August 2011
Verified
Journal Article
Closed access
Roberto De GiorgioRoberto De Giorgio
Roberto De Giorgio
RCR Cestari
R Cestari
RCR Corinaldesi
R Corinaldesi
VSV Stanghellini
V Stanghellini
GBG Barbara
G Barbara
SCSalvatore Cucchiara
Salvatore Cucchiara